Amyotrophic Lateral Sclerosis (ALS) Flashcards
1
Q
What is ALS?
A
- progressive, incurable neurodegenerative disease
- causes muscle weakness and eventually death
- a disease of the motor tracts of the lateral column and the anterior horn of the spinal cord
2
Q
What factors can cause ALS?
A
- Most cases are sporatic, few are familial
- Males > females (equalizes with age)
- most pts are diagnosed between 55-75 years
- rarely occur in 20s and 30s
- white prs are 2x more likely to develop ALS
- more common among non-hispanics
- genetic factor lends to ~10% of diagnosis
3
Q
What is ALS pathophysiology?
A
- no single cause: several different hypothesis – contribute to progressive loss of motor
- excitotoxicity caused by excessive glutamate leading to entry of Ca2+ into cells (cell death via lipid peroxidation, nucleic acid damage, mitochondrial disruption)
- accumulation of toxic free radicals
- motor neruons replaced with gliosis after neuron death –> leads to scarring in CNS
- bilateral changes in white matter
- spinal cord becomes atrophic
- clear overlap with frontotemportal dementia
- impairment afferects functions in different areas (Limb, Bulbar, Axial, Respiratory)
- progresses as more neurons degenerate and die > muscles are no longer nerve pulses > muscles shrink and waste aways
4
Q
What are the critera for ALS diagnosis?
A
- Progressive upper and lower motor neuron symptoms and signs in one limb or body segment
or - progressive lower motor neuron symptoms and signs in at least two body segments
and - absesne of electrophysologic, neuroimaging, and pathologic evidence of other disease processes
5
Q
What are the signs and symptoms of ALS upper motor neuron?
A
- limb: slowness of movement, incoordiantion, stiffness, poor dexterity of arms/hands, spastic gait and poor balance
- bulbar: dysarthria, dysphagia, pseudobular affect, laryngospasm, sialorrhea
- axial: stiffness, imbalance
6
Q
What are the signs and symptoms of ALS lower motor neuron?
A
- limb: weakness, atrophy, fasciculations, cramps
- bulbar: dysathria, dysphagia, incomplete eye closure
- axial: difficulty holding up head, maintaining erect posture
- respiratory: weakness of diaghragm causes dysphenea at rest, reduced vocal volume, tachypnea, sleep disordered breathing
7
Q
What is the clinical course of ALS?
A
- diagnosis early is difficult: often >13-18 months after symptom onset
- usually starts with nerve atrophy in the hands or feet: gradual muscle weekness and wasting arms, legs; muscle fasciculations; difficulty swallowing, speaking, breathing; muscle stiffness, bodily pains, cramps
- fatal, progressive disease: average survival time is 3 years after symptom onset, stable plateus are rare
8
Q
Whar is the ALS cause of death?
A
respiratory failure, pneumonia
9
Q
What is the goal of ALS treatment?
A
- slow disease progression
- increase time to need for tracheostomy or permanent assitied ventilation
- prolong survival
10
Q
What are the three aproved agents of trearment for ALS?
A
- riluzole- start with this
- ederavone
- PB- TURSO
(add new agents within a few weeks of eo)
11
Q
What is the the neuroprotective effect of Riluzole?
A
- blocks presynaptic release of glutamate byt bocking pre-synaptic calsium channels
- prolongs median survival by 2-3 months - better for pts with bulbar onset
- major CYP1A2 subtrate - level decreased in smokers
- high fat meal - 20% AUC decrease
12
Q
common adverse effects of riluzole?
A
- nausea
- dizziness
- general weakness
- numbness
- increased LFTs
13
Q
MoA of endaravone?
A
free radical scavenger
* efficacy in combo with riluzole
14
Q
What is the MoA of PB-TURSO?
A
- can reduce neuronal cell death in vitro
- mechanism unclear
- reactive oxygen species scavengers
- slower meadian rate of functional decline seen in trials (75% of paitents were also receivign riluzole and endaravone)
15
Q
What are the ADEs of PB-TURSO?
A
- avoid in moderate to severe hepatic/ renal impairment
- high fat meal decreases AUC by ~50%
- Common adverse effects:
1. abdominal pain
2. diarrhea
3. nausea
4. sialorrhea- excessive saliva flow
5. fatigue
6. dizziness